Amneal CEO to Present at Goldman Sachs Healthcare Conference — Amneal Pharmaceuticals, Inc.

Event summary

Amneal Pharmaceuticals' Co-CEO Chirag Patel will present at the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026.
The presentation will take place at 8:40 AM EDT and will be available via live webcast.
Amneal operates a portfolio of approximately 300 complex generic, specialty, and biosimilar medicines.
The company delivers over 160 million prescriptions annually, primarily in the United States.

The big picture

Amneal's participation in the Goldman Sachs conference underscores its focus on expanding access to affordable and innovative medicines. The event provides a platform for the company to highlight its strategic positioning in the biopharmaceutical industry, particularly in the complex generic, specialty, and biosimilar markets. With a portfolio delivering over 160 million prescriptions annually, Amneal is well-positioned to capitalize on trends in healthcare accessibility and innovation.

What we're watching

Strategic Messaging: How Amneal will position its portfolio of 300 medicines to attract investors and partners during the presentation.
Market Expansion: Whether Amneal can sustain its growth in the U.S. market while expanding its reach globally.
Execution Risk: The pace at which Amneal can integrate its diverse segments—Affordable Medicines, Specialty, and AvKARE—into a cohesive growth strategy.